# OnCo record nuclidium (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nuclidium/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nuclidium" ;
  schema:name "Nuclidium"@en ;
  schema:alternateName "NUCLIDIUM"@en, "Nuclidium AG"@en ;
  schema:description "Nuclidium is a Swiss company building radioactive medicines around copper instead of the more usual gallium and lutetium: one copper isotope for a scan that finds the cancer, a sister isotope to treat it. Its first programmes are in advanced prostate cancer, neuroendocrine tumours and breast cancer."@en ;
  schema:url <https://onco.cc/companies/nuclidium/>, <https://nuclidium.com/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://nuclidium.com/>, <https://nuclidium.com/about-us/>, <https://nuclidium.com/pipeline/>, <https://nuclidium.com/news/> ;
  schema:addressCountry "CH" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/breast-cancer/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/>, <https://onco.cc/fronts/imaging/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/psma-pet/>, <https://onco.cc/technologies/sstr-pet/> ;
  onco:targets <https://onco.cc/targets/psma/>, <https://onco.cc/targets/sstr2/> .